GlassScriptPhysician profile
Hannah D Robison
NPI 1780298034
$1,041.04
in general payments reported to CMS, 2019-2025
14 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $126 · 2022: $303 · 2023: $274 · 2024: $191 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $612.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $489.92 | 2021-2025 | Azstarys |
| Tris Pharma INC | $127.80 | 2021-2023 | Quillivant, Quillichew Er, Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $111.90 | 2021-2022 | |
| Ironshore Pharmaceuticals INC. | $72.65 | 2024 | |
| Collegium Pharmaceutical, INC. | $54.25 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $41.18 | 2021-2023 | Vaxneuvance, Rotateq, Vaxelis |
| Hologic Sales and Service, LLC | $21.63 | 2025 | Aptima |
| Ultragenyx Pharmaceutical INC. | $21.20 | 2023 | |
| Vapotherm INC | $20.87 | 2022 | |
| Sanofi Pasteur INC. | $19.07 | 2023 | |
| Genentech USA, INC. | $17.94 | 2021 | |
| Sanofi-Aventis U.S. LLC | $16.68 | 2024 | |
| Kyowa Kirin, INC. | $16.08 | 2024 | Crysvita |
| Organon LLC | $9.87 | 2022-2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Robison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.